06:14:07 EDT Tue 23 Apr 2024
Enter Symbol
or Name
USA
CA



Emerald Health Therapeutics Inc
Symbol EMH
Shares Issued 93,064,798
Close 2017-09-18 C$ 1.25
Market Cap C$ 116,330,998
Recent Sedar Documents

Emerald Health releases proprietary Island Mist strain

2017-09-18 10:28 ET - News Release

Dr. Bin Huang reports

EMERALD HEALTH THERAPEUTICS LAUNCHES ISLAND MIST, ONE OF CANADA'S HIGHEST CBD AND CBD TO THC RATIO DRIED FLOWER PRODUCTS

Emerald Health Therapeutics Inc. has released Island Mist, its proprietary high-cannabidiol (CBD) and high CBD-to-THC-ratio dried flower product. This indica-dominant strain, which came out of Emerald's broad seed bank through extensive screening and characterization, contains 15.9 per cent CBD and just 0.4 per cent THC, a ratio of 40:1. This product can be purchased by holders of a medical licence registered with Emerald Health Botanicals (Botanicals), Therapeutics' wholly owned subsidiary and a licensed producer under Access to Cannabis for Medical Purposes Regulations (ACMPR).

Botanicals currently sells a line of six dried flower products, including four strains with THC levels ranging from 16.3 per cent to 21.5 per cent; a high CBD strain; and a strain containing both THC and CBD. Botanicals now offers eight oils with varying levels of THC, THCA, CBD and THC-to-CBD ratios. This product line includes the company's recently launched CBD-25 and CBD-50 medical cannabis oils containing approximately 25 milligrams and 50 mg of CBD per millilitre. Management believes CBD-50 contains the highest amount of CBD per millilitre on the ACMPR market today. CBD-50 provides a unique option to doctors and patients seeking high CBD potency with minimal THC.

"Island Mist offers patients who prefer dried flower with significant CBD and minute amounts of THC and thus little to no psychoactive effects," said Dr. Bin Huang, president and chief executive officer of Emerald. "We have built a balanced product line that we will add to with our continuing pursuit of distinct products to meet different needs and expectations in the ACMPR marketplace and the anticipated legal Canadian recreational market in 2018."

About Emerald Health Therapeutics Inc.

Emerald Health operates primarily through Emerald Health Botanicals Inc., a wholly owned subsidiary of the company and a licensed producer under the ACMPR. Botanicals is authorized to produce and sell both dried medical cannabis flower and medical cannabis oil in Canada. Botanicals currently operates an indoor facility in Victoria, B.C., and is progressing on expansion plans for a 32-acre property in Metro Vancouver and a joint venture with Village Farms utilizing a 25-acre existing greenhouse complex in Delta, B.C. Botanicals is one of Canada's most medically focused licensed producers, with a team highly experienced in life sciences product development and large-scale agribusiness.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.